Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | fatty acid elongase, putative | 0.0045 | 0.0263 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0183 | 0.2416 | 0.2285 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.0345 | 0.4946 | 0.4858 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0049 | 0.0334 | 0.0167 |
Leishmania major | dihydrofolate reductase-thymidylate synthase | 0.0669 | 1 | 1 |
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase, putative | 0.0318 | 0.4529 | 0.4225 |
Mycobacterium tuberculosis | 3-oxoacyl-[acyl-carrier-protein] synthase III FabH (beta-ketoacyl-ACP synthase III) (KAS III) | 0.0345 | 0.4946 | 0.0762 |
Trypanosoma brucei | dihydrofolate reductase-thymidylate synthase | 0.0669 | 1 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0049 | 0.0334 | 0.0167 |
Onchocerca volvulus | 0.0669 | 1 | 1 | |
Entamoeba histolytica | fatty acid elongase, putative | 0.0045 | 0.0263 | 1 |
Plasmodium falciparum | beta-ketoacyl-ACP synthase III | 0.0345 | 0.4946 | 0.4665 |
Schistosoma mansoni | hypothetical protein | 0.0331 | 0.472 | 0.4629 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0318 | 0.4529 | 0.5 |
Loa Loa (eye worm) | camk/mapkapk/mnk protein kinase | 0.0412 | 0.599 | 0.5988 |
Brugia malayi | hypothetical protein | 0.0318 | 0.4529 | 0.4526 |
Schistosoma mansoni | single-minded | 0.0052 | 0.0383 | 0.0217 |
Brugia malayi | bHLH-PAS transcription factor | 0.0039 | 0.017 | 0.0165 |
Echinococcus granulosus | geminin | 0.0183 | 0.2416 | 0.2285 |
Onchocerca volvulus | 0.0559 | 0.8284 | 0.8254 | |
Brugia malayi | orotate phosphoribosyltransferase family protein | 0.0062 | 0.0527 | 0.0521 |
Echinococcus multilocularis | thymidylate synthase | 0.0669 | 1 | 1 |
Brugia malayi | PAS domain containing protein | 0.0052 | 0.0383 | 0.0378 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0049 | 0.0334 | 0.0167 |
Schistosoma mansoni | aryl hydrocarbon receptor | 0.0052 | 0.0383 | 0.0217 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0049 | 0.0334 | 0.0167 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0045 | 0.0263 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0176 | 0.2311 | 0.2307 |
Chlamydia trachomatis | oxoacyl-ACP synthase III | 0.0345 | 0.4946 | 0.5 |
Plasmodium vivax | bifunctional dihydrofolate reductase-thymidylate synthase, putative | 0.0669 | 1 | 1 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0049 | 0.0334 | 0.0167 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0049 | 0.0334 | 0.0167 |
Mycobacterium leprae | PROBABLE THYMIDYLATE SYNTHASE THYA (TS) (TSASE) | 0.0669 | 1 | 1 |
Plasmodium vivax | beta-ketoacyl-acyl carrier protein synthase III precursor, putative | 0.0345 | 0.4946 | 0.4665 |
Toxoplasma gondii | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0669 | 1 | 1 |
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase | 0.0669 | 1 | 1 |
Loa Loa (eye worm) | thymidylate synthase | 0.0669 | 1 | 1 |
Trypanosoma brucei | orotidine-5-phosphate decarboxylase/orotate phosphoribosyltransferase, putative | 0.0062 | 0.0527 | 0.0527 |
Brugia malayi | Protein kinase domain containing protein | 0.0412 | 0.599 | 0.5988 |
Brugia malayi | hypothetical protein | 0.0039 | 0.017 | 0.0164 |
Brugia malayi | hypoxia-induced factor 1 | 0.0162 | 0.2098 | 0.2094 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0045 | 0.0263 | 1 |
Trypanosoma brucei | RNA helicase, putative | 0.0331 | 0.472 | 0.472 |
Echinococcus granulosus | uridine 5' monophosphate synthase | 0.0062 | 0.0527 | 0.0363 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0045 | 0.0263 | 1 |
Loa Loa (eye worm) | hypoxia-induced factor 1 | 0.0162 | 0.2098 | 0.2094 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0049 | 0.0334 | 0.0329 |
Echinococcus granulosus | thymidylate synthase | 0.0669 | 1 | 1 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.0345 | 0.4946 | 0.4858 |
Schistosoma mansoni | hypothetical protein | 0.0183 | 0.2416 | 0.2285 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0049 | 0.0334 | 0.0167 |
Plasmodium falciparum | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0669 | 1 | 1 |
Mycobacterium tuberculosis | Probable thymidylate synthase ThyA (ts) (TSASE) | 0.0669 | 1 | 1 |
Echinococcus multilocularis | geminin | 0.0183 | 0.2416 | 0.2285 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0049 | 0.0334 | 0.0329 |
Schistosoma mansoni | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0669 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | orotidine-5'-phosphate decarboxylase | 0.0621 | 0.9246 | 1 |
Mycobacterium ulcerans | thymidylate synthase | 0.0669 | 1 | 1 |
Brugia malayi | hypothetical protein | 0.0176 | 0.2311 | 0.2307 |
Schistosoma mansoni | orotidine 5'-phosphate decarboxylase | 0.0062 | 0.0527 | 0.0363 |
Echinococcus multilocularis | uridine 5' monophosphate synthase | 0.0062 | 0.0527 | 0.0363 |
Loa Loa (eye worm) | orotate phosphoribosyltransferase | 0.0062 | 0.0527 | 0.0521 |
Mycobacterium ulcerans | beta-ketoacyl synthase-like protein | 0.0345 | 0.4946 | 0.4858 |
Mycobacterium ulcerans | orotidine 5'-phosphate decarboxylase | 0.0062 | 0.0527 | 0.0363 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
ID50 (functional) | > 1000 uM kg-1 | Inhibition of rat passive cutaneous anaphylaxis(PCA) reaction was determined after oral administration | ChEMBL. | 6183427 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.